Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $14.7500 (0.27%) ($14.6400 - $14.7500) on Mon. Aug. 30, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.04% (three month average) | RSI | 72 | Latest Price | $14.7500(0.27%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 1.7% a day on average for past five trading days. | Weekly Trend | ATRA advances 6.7% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(52%) ARKG(45%) ARKK(45%) IBB(45%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -1.52% in a week (0% probabilities). VIXM(-37%) VXX(-27%) IGOV(-15%) UNG(-12%) TLT(-10%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.52% (StdDev 3.04%) | Hourly BBV | 0.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $14.14(4.31%) | 10 Day Moving Average | $13.44(9.75%) | 20 Day Moving Average | $13.02(13.29%) | To recent high | -11% | To recent low | 22.9% | Market Cap | $1.096b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |